Факторы, участвующие в модулировании механизмов иммунной защиты легких при пневмонии


https://doi.org/10.21055/0370-1069-2012-1(111)-81-83

Полный текст:


Аннотация

В обзоре представлены современные данные о факторах, участвующих в модулировании механизмов иммунной защиты легких при пневмонии. Рассмотрена роль белка SP-A в обеспечении резистентности к инфекционным болезням легких. Показано отрицательное воздействие озона на белок SP-A. Отмечено наличие гендерных особенностей в заболеваемости пневмонией и чувствительности к озону.

Об авторе

А. Н. Микеров
Саратовский государственный медицинский университет им. В.И.Разумовского
Россия


Список литературы

1. Abraham E. Neutrophils and acute lung injury. Crit Care Med. 2003; 31:S195-9.

2. Annesi-Maesano I., Agabiti N., Pistelli R., Couilliot M.F., Forastiere F. Subpopulations at increased risk of adverse health outcomes from air pollution. Eur. Respir. J. Suppl. 2003; 40:57s-63s.

3. Bassett D., Elbon-Copp C., Otterbein S., Barraclough-Mitchell H., Delorme M., Yang H. Inflammatory cell availability affects ozone-induced lung damage. J. Toxicol. Environ. Health A. 2001; 64:547-65.

4. Bernstein J.A., Alexis N., Barnes C., Bernstein I.L., Bernstein J.A., Nel A., Peden D., Diaz-Sanchez D., Tarlo S.M., Williams P.B. Health effects of air pollution. J. Allergy Clin. Immunol. 2004; 114:1116-23.

5. Borron P., McCormack F.X., Elhalwagi B.M., Chroneos Z.C., Lewis J.F., Zhu S., Wright J.R., Shepherd V.L., Possmayer F., Inchley K., Fraher L.J. Surfactant protein A inhibits T cell proliferation via its collagen-like tail and a 210-kDa receptor. Am. J. Physiol. Lung Cell. Mol. Physiol. 1998; 275:L679-86.

6. Brinker K.G., Garner H., Wright J.R. Surfactant protein A modulates the differentiation of murine bone marrow-derived dendritic cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2003; 284:L232-41.

7. Caracta C.F. Gender differences in pulmonary disease. Mt. Sinai. J. Med. 2003; 70:215-24.

8. Devlin R.B., McDonnell W.F., Mann R., Becker S., House D.E., Schreinemachers D., Koren H.S. Exposure of humans to ambient levels of ozone for 6.6 hours causes cellular and biochemical changes in the lung. Am. J. Respir. Cell Mol. Biol. 1991; 4:72-81.

9. Fischer P., Hoek G., Brunekreef B., Verhoeff A., van Wijnen J. Air pollution and mortality in The Netherlands: are the elderly more at risk? Eur. Respir. J. 2003; 21(40 Suppl):34s-38s.

10. Gannon C.J., Pasquale M., Tracy J.K., McCarter R.J., Napolitano L.M. Male gender is associated with increased risk for postinjury pneumonia. Shock. 2004; 21:410-4.

11. Gordon H.S., Rosenthal G.E. The relationship of gender and in-hospital death: increased risk of death in men. Med. Care. 1999; 37:318-24.

12. Hollingsworth J.W., Kleeberger S.R., Foster W.M. Ozone and pulmonary innate immunity. Proc. Am. Thorac. Soc. 2007; 4:240-6.

13. Horstman D.H., Folinsbee L.J., Ives P.J., Abdul-Salaam S., McDonnell W.F. Ozone concentration and pulmonary response relationships for 6.6-hour exposures with five hours of moderate exercise to 0.08, 0.10, and 0.12 ppm. Am. Rev. Respir. Dis. 1990; 142:1158-63.

14. Kehrl H.R., Vincent L.M., Kowalsky R.J., Horstman D.H., O'Neil J.J., McCartney W.H., Bromberg P.A. Ozone exposure increases respiratory epithelial permeability in humans. Am. Rev. Respir. Dis. 1987; 135:1124-8.

15. Khubchandani K.R., Oberley R.E., Snyder J.M. Effects of surfactant protein A and NaCl concentration on the uptake of Pseudomonas aeruginosa by THP-1 cells. Am. J. Respir. Cell Mol. Biol. 2001; 25:699-706.

16. Kudo K., Sano H., Takahashi H., Kuronuma K., Yokota S., Fujii N., Shimada K., Yano I., Kumazawa Y., Voelker D.R., Abe S., Kuroki Y. Pulmonary collectins enhance phagocytosis of Mycobacterium avium through increased activity of mannose receptor. J. Immunol. 2004; 172:7592-602.

17. Kulle T.J., Sauder L.R., Hebel J.R., Chatham M.D. Ozone response relationships in healthy nonsmokers. Am. Rev. Respir. Dis. 1985; 132:36-41.

18. Loeb M., McGeer A., McArthur M., Walter S., Simor A.E. Risk factors for pneumonia and other lower respiratory tract infections in elderly residents of long-term care facilities. Arch. Intern. Med. 1999; 159:2058-64.

19. Medina-Ramon M., Zanobetti A., Schwartz J. The effect of ozone and PM10 on hospital admissions for pneumonia and chronic obstructive pulmonary disease: a national multicity study. Am. J. Epidemiol. 2006; 163:579-88.

20. Mikerov A.N., Gan X., Umstead T.M., Miller L., Chinchilli V.M., Phelps D.S., Floros J. Sex differences in the impact of ozone on survival and alveolar macrophage function of mice after Klebsiella pneumoniae infection. Respir. Res. 2008; 9:24.

21. Mikerov A.N., Haque R., Gan X., Guo X., Phelps D.S., Floros J. Ablation of SP-A has a negative impact on the susceptibility of mice to Klebsiella pneumoniae infection after ozone exposure: sex differences. Respir. Res. 2008; 9:77.

22. Mikerov A.N., Umstead T.M., Gan X., Huang W., Guo X., Wang G., Phelps D.S., Floros J. Impact of ozone exposure on the phagocytic activity of human surfactant protein A (SP-A) and SP-A variants. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008; 294:L121-30.

23. Mikerov A.N., Wang G., Umstead T.M., Zacharatos M., Thomas N.J., Phelps D.S., Floros J. Surfactant protein A2 (SP-A2) variants expressed in CHO cells stimulate phagocytosis of Pseudomonas aeruginosa more than Do SP-A1 variants. Infect. Immun. 2007; 75:1403-12.

24. Mikerov A.N., White M., Hartshorn K., Wang G., Floros J. Inhibition of hemagglutination activity of influenza A viruses by SP-A1 and SP-A2 variants expressed in CHO cells. Med. Microbiol. Immunol. 2008; 197(1):9-12

25. Muller B., Seifart C., Barth P.J. Effect of air pollutants on the pulmonary surfactant system. Eur. J. Clin. Invest. 1998; 28:762-77.

26. Nielsen H.C. Testosterone regulation of sex differences in fetal lung development. Proc. Soc. Exp. Biol. Med. 1992; 199:446-52.

27. Oberley R.E., Ault K.A., Neff T.L., Khubchandani K.R., Crouch E.C., Snyder J.M. Surfactant proteins A and D enhance the phagocytosis of Chlamydia into THP-1 cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2004; 287:L296-306.

28. Oberley R.E., Snyder J.M. Recombinant human SP-A1 and SP-A2 proteins have different carbohydrate-binding characteristics. Am. J. Physiol. Lung Cell. Mol. Physiol. 2003; 284:L871-81.

29. Oosting R.S., van Greevenbroek M.M., Verhoef J., van Golde L.M., Haagsman H.P. Structural and functional changes of surfactant protein A induced by ozone. Am. J. Physiol. 1991; 261: L77-83.

30. Oosting R.S., Van Iwaarden J.F., Van Bree L., Verhoef J., Van Golde L.M., Haagsman H.P. Exposure of surfactant protein A to ozone in vitro and in vivo impairs its interactions with alveolar cells. Am. J. Physiol. 1992; 262:L63-8.

31. Peel J.L., Tolbert P.E., Klein M., Metzger K.B., Flanders W.D., Todd K., Mulholland J.A., Ryan P.B., Frumkin H. Ambient air pollution and respiratory emergency department visits. Epidemiology. 2005; 16(2):164-74.

32. Tagaram H.R., Wang G., Umstead T.M., Mikerov A.N., Thomas N.J., Graff G.R., Hess J.C., Thomassen M.J., Kavuru M.S., Phelps D.S., Floros J. Characterization of a human surfactant protein A1 (SP-A1) gene-specific antibody; SP-A1 content variation among individuals of varying age and pulmonary health. Am. J. Physiol. Lung Cell. Mol. Physiol. 2007; 292(5):L1052-63.

33. van Iwaarden F., Welmers B., Verhoef J., Haagsman H.P., van Golde L.M. Pulmonary surfactant protein A enhances the host-defense mechanism of rat alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 1990; 2:91-8.

34. Voss T., Melchers K., Scheirle G., Schafer K.P. Structural comparison of recombinant pulmonary surfactant protein SP-A derived from two human coding sequences: implications for the chain composition of natural human SP-A. Am. J. Respir. Cell Mol. Biol. 1991; 4:88-94.

35. Wang G., Myers C., Mikerov A., Floros J. Effect of cysteine 85 on biochemical properties and biological function of human surfactant protein A variants. Biochemistry. 2007; 46:8425-35.

36. Wang G., Phelps D.S., Umstead T.M., Floros J. Human SP-A protein variants derived from one or both genes stimulate TNF-alpha production in the THP-1 cell line. Am. J. Physiol. Lung Cell. Mol. Physiol. 2000; 278: L946-54.

37. Wang G., Umstead T.M., Phelps D.S., Al Mondhiry H., Floros J. The effect of ozone exposure on the ability of human surfactant protein A variants to stimulate cytokine production. Environ. Health Perspect. 2002; 110:79-84.

38. Wright J.R., Youmans D.C. Pulmonary surfactant protein A stimulates chemotaxis of alveolar macrophage. Am. J. Physiol. Lung Cell. Mol. Physiol. 1993; 264:L338-44.

39. Wu H., Kuzmenko A., Wan S., Schaffer L., Weiss A., Fisher J.H., Kim K.S., McCormack F.X. Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability. J. Clin. Invest. 2003; 111:1589-602.


Дополнительные файлы

Для цитирования: Микеров А.Н. Факторы, участвующие в модулировании механизмов иммунной защиты легких при пневмонии. Проблемы особо опасных инфекций. 2012;(1(111)):81-83. https://doi.org/10.21055/0370-1069-2012-1(111)-81-83

For citation: Mikerov A.N. Factors Participating in Modulating the Mechanisms of Immune Protection of Lungs during Pneumonia. Problems of Particularly Dangerous Infections. 2012;(1(111)):81-83. (In Russ.) https://doi.org/10.21055/0370-1069-2012-1(111)-81-83

Просмотров: 41

Обратные ссылки

  • Обратные ссылки не определены.


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 0370-1069 (Print)
ISSN 2658-719X (Online)